Fibroglandular tissue is the functional, non-fatty part of your breast. It includes the glands that produce milk (lobules), the ducts that carry milk to the nipple, and the fibrous connective tissue that holds everything in place. Every breast contains a mix of fibroglandular tissue and fatty tissue, and the ratio between the two varies widely from person to person. If this term showed up on your mammogram report, it’s describing your breast’s normal composition, not a disease or abnormality.
What Fibroglandular Tissue Is Made Of
Your breast has three basic building blocks. Glandular tissue is the milk-producing system: small lobes that create milk and a network of ducts that channel it to the nipple. Fibrous tissue is the structural scaffolding that keeps all of that in place. Together, these two components are called fibroglandular tissue. The rest of your breast is fatty tissue, which fills in around and between the fibroglandular structures.
On a mammogram, fibroglandular tissue appears white or light gray, while fat appears dark. The more fibroglandular tissue you have relative to fat, the “denser” your breasts are considered. This is a normal anatomical variation, not a medical problem.
The Four Breast Density Categories
Radiologists classify breast density into four standardized categories based on how much fibroglandular tissue they see on your mammogram. You’ll often see these referenced by letters (a through d) or by their descriptive names:
- Entirely fatty (category a): Almost all fatty tissue with very little fibroglandular tissue. About 10% of women fall here.
- Scattered fibroglandular densities (category b): Mostly fatty tissue with some patches of fibroglandular tissue scattered throughout. This is the most common category alongside the next one, found in about 40% of women.
- Heterogeneously dense (category c): Many areas of fibroglandular tissue with some fatty areas mixed in. Also found in about 40% of women.
- Extremely dense (category d): Almost entirely fibroglandular tissue with very little fat. About 10% of women fall here.
Categories c and d are considered “dense breasts.” Roughly half of all women have dense breasts, so if your report mentions this, you’re in very common company.
Why It Shows Up on Your Mammogram Report
A federal rule now requires mammography facilities across the United States to include breast density information in every report sent to patients. Before this federal mandate took effect, 39 states and Washington, D.C., already had their own reporting laws. The goal is to make sure you know your density category, because it affects both how well mammograms work for you and your overall breast cancer risk profile.
If your report says “scattered fibroglandular densities” or “scattered areas of fibroglandular density,” it means you’re in category b. Your breasts are mostly fatty with some denser patches. This is considered a normal finding and the single most common category.
How Density Affects Mammogram Accuracy
Fibroglandular tissue and potential tumors both appear white on a mammogram. This creates a masking effect: dense tissue can hide a cancer the same way a snowball is hard to spot in a snowstorm. The more fibroglandular tissue you have, the harder it becomes for radiologists to detect small abnormalities.
This masking effect is measurable. Among cancers that develop between scheduled screenings (called interval cancers, meaning they weren’t caught on the most recent mammogram), 63% occur in women with dense breasts. For women with mostly fatty tissue, mammograms are highly effective. For women with extremely dense tissue, the odds of a cancer being missed go up considerably.
Fibroglandular Tissue and Cancer Risk
Dense breast tissue isn’t just a screening challenge. It’s also an independent risk factor for breast cancer. Women with the highest amounts of dense tissue have roughly 2.8 times the breast cancer risk compared to women with the least dense tissue, after adjusting for other factors like body weight. To put that in perspective, this is a moderate increase in relative risk. It doesn’t mean dense breasts will lead to cancer. Most women with dense breasts never develop breast cancer. But the association is strong enough that density is now factored into risk assessment tools.
What Changes Your Breast Density
Several factors influence how much fibroglandular tissue you have.
Age and menopause are the biggest drivers of change. As you age, fibroglandular tissue gradually gets replaced by fatty tissue in a process called involution. Most women see their breast density decrease after menopause.
Body weight plays a role, though not in the way you might expect. Higher body weight is strongly linked to larger overall breast size, mostly because of increased fatty tissue. But the proportion of dense-to-fatty tissue typically shifts toward more fat at higher weights, which can actually lower density on a mammogram. Genetics account for roughly a third of the overlap between body weight and breast size.
Hormone replacement therapy (HRT) can reverse some of the natural density decline that comes with menopause. Women taking combined estrogen and progesterone therapy see the largest effect. In one analysis, combined HRT users had a 6.3% increase in density over baseline, while women not taking hormones saw a slight decrease. Current HRT users were about twice as likely to have dense breasts compared to women who never used HRT. Estrogen-only therapy also increases density, but to a lesser degree. The effect appears to pause the normal process of breast tissue thinning rather than creating new dense tissue in most women.
Supplemental Screening Options
If you have dense breasts (categories c or d), your doctor may discuss additional screening beyond standard mammography. The options and recommendations vary depending on your overall risk level, not just your density.
Breast ultrasound is the most commonly recommended add-on for women with dense tissue. It can find cancers that mammograms miss, particularly small masses hidden by fibroglandular tissue. Several major radiology organizations, including the American College of Radiology, support supplemental ultrasound for women with dense breasts.
Breast MRI is the most sensitive screening tool available, but guidelines generally reserve it for women whose lifetime breast cancer risk exceeds 20%, based on a combination of density, family history, genetics, and other factors. The European Society of Breast Imaging takes a broader approach, recommending MRI for women with extremely dense breasts every two to four years regardless of other risk factors. North American guidelines tend to favor a more individualized approach, weighing additional risk factors before recommending MRI.
3D mammography (tomosynthesis) is another option that improves cancer detection in dense tissue compared to standard 2D mammograms. It takes images in thin slices, which helps separate overlapping tissue and reduces the masking effect.
If your mammogram report mentions fibroglandular tissue and you’re unsure what it means for your screening plan, your density category combined with your personal and family history will determine whether additional imaging makes sense for you.